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Abstract 
Diarrhea is the leading cause of mortality in beef and dairy calves during the first week of life and 
results in substantial financial loss [1]. Diarrhea is a multifactorial disease and can be infectious or 
non-infectious. However, in the majority of calves, infectious organisms, especially Cryptospori-
dium parvum, rotavirus, coronavirus, and E. coli, are the primary cause [2]. The aim of this study 
was to generate a decision tree, based on prevalence, diagnostic testing and treatment and to es-
timate associated costs or risk. For each of the four main pathogens, two principal approaches are 
outlined and compared. The first approach relies on a detailed diagnostic workup and allows for 
specific etiological treatment. The second approach relies on the trial-and-error method, which 
involves the use of a first-choice antibiotic, followed by a second- and third-choice antibiotic if the 
previous ones failed to resolve the disease. In Switzerland, the prevalence of diarrheic calves in-
fected with E. coli is approximately 1% suggesting that the use of antimicrobials for the treatment 
of scouring calves, in the absence of a diagnostic workup, is not always justified. However, for all 
four major pathogens, the trial-and-error method affords cheaper treatment compared with treat- 
ment based on an etiological diagnosis. This creates a quandary in view of the current worldwide 
efforts to reduce the use of antibiotics in animal agriculture. 
 
Keywords 
Bovine, Calf, Antibiotic, Antimicrobial Susceptibility Testing, Decision Tree Analysis, Diarrhea 
 
 
1. Introduction 
Diarrhea is the leading cause of death in beef and dairy calves in the first week of life [1] and has a major eco-
nomic impact on animal production. Calf losses, reduced weight gains, increased workload, and the cost of 
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treatment and preventive measures result in substantial financial expenditures [3]. 
Diarrhea is a multifactorial disease and may be caused by viruses, bacteria or parasites. Infectious diarrhea is 
often a sequel to failure of passive transfer because of inadequate colostrum quality or quantity. Crowding, im-
mune status, and environmental and management factors also play important roles in the pathogenesis of diarr-
hea [5]. The four most prevalent infectious microorganisms found in calves with diarrhea are Cryptosporidium 
parvum, rotavirus, coronavirus, and enterotoxic E. coli. These agents are responsible for 75% to 95% of all cases 
of diarrhea worldwide in newborn calves [2]. Mixed infections and consecutive infections by different infectious 
agents are common [2] [4]. 
The etiological diagnosis in a calf with diarrhea usually requires laboratory testing and typically cannot be 
made based on the clinical signs and the type of diarrhea alone. The establishment of an etiological diagnosis is 
crucial, especially in herd problems, to initiate specific treatment and metaphylactic and prophylactic measures 
[5]. Selection of an effective treatment for scouring calves can be difficult without an etiological diagnosis. 
The use of antibiotics for the treatment of diarrhea in calves is controversial. A recent review article on anti-
microbial decision making [1] referred to studies that favored the use of antibiotics for the treatment of calves 
with diarrhea [6] as well as studies that discouraged the use of antibiotics because of contraindication or lack of 
efficacy [7]. Several studies have shown that antibiotics can reduce the mortality rate and shorten the duration of 
diarrhea [8]. The two main indications for the use of antibiotics for the treatment of scouring calves are the pre-
vention of secondary bacteremia and the reduction in the number of coliform bacteria in the small intestine [8]. 
This review investigated the overall cost of veterinary services, diagnostic tests, treatment, reduced weight gain, 
and mortality in calves with diarrhea. The goal was to create a decision tree to show how calf diarrhea can be 
addressed diagnostically and therapeutically. Special emphasis was given to comparison of the trial-and-error 
method and treatment based on an etiological diagnosis after the identification of the infectious agent and evalu-
ation of potential resistance to therapeutic drugs. The different risks that were compared using this decision tree 
were defined as cost multiplied by probability. The prevalence of the four major diarrheal pathogens in calves in 
Switzerland was multiplied by veterinary costs. A further goal was to examine whether the cost of antimicrobial 
susceptibility testing was justified; the trial-and-error method minimized the cost of diagnostic testing but also 
minimized the likelihood of successful treatments, whereas antimicrobial susceptibility testing increased the cost 
of diagnostic testing but minimized the number of futile antibiotic treatments. 
2. Animals, Materials and Methods 
The operational approach needed no clearance by an animal protection ethics committee, since all animals were 
treated when clinically ill. All raw data were extracted from a Filemaker®-database (FileMaker, Inc. 5201 Pa-
trick Henry Drive, Santa Clara, CA) where all herds transferred to the Section for Ambulatory Field Clinic and 
Herd Health, Department of Farm Animals, University of Zurich were registered from 1990 until 2013. The data 
were transferred to Stata® for further statistical evaluation such as means and counts for specific selections (Sta-
ta statistical software: release 12.0. Statcorp LP, College Station, TX, USA). The decision tree was analyzed 
according to Altman [9]. The decision tree was divided into four parts with one overview for convenience 
(Figures 1-5). Four trees have been drawn that show only one branch in detail. The division was made accord-
ing to the four main diarrhea pathogens. Each field was marked with a combination of a letter and a number. 
The boxes with the rounded corners represent a free choice. In addition, they contain costs (K). The boxes with 
the pointed corners show the possible consequences of a given decision. They include the probability (P) linked 
to a particular decision and the costs thereby incurred (K). The information relating to probability and cost is 
given in Tables 1-6. The risks expressed as probability multiplied by cost (RK) are listed. The boxes in Figures 
1-5, labeled “B2 non-infectious cause” and those containing information about other infectious agents are shown 
for the sake of comprehensiveness and are not dealt with further because they do not relate to the comparison of 
targeted diagnostic procedures and and the trial-and-error method. 
The sources for the decision tree were visited between January 2014 and March 2015 in the following three 
databases: PubMed (http://www.ncbi.nlm.nih.gov/pubmed), ScienceDirect (http://www.sciencedirect.com/) and 
cabdirect (http://www.cabdirect.org/). The following search terms were used in different combinations: calf/ 
calves diarrhea/scours, cryptosporidiosis, rotavirus, coronavirus, E. coli, treatment, fluids, antimicrobials, pre-
valence Switzerland. The weighted average of the listed prevalence was calculated for the calculation of the 
prevalences in the decision tree. The drugs were selected according to the treatment guidelines used at our clinic 
(Cryptosporidium parvum: Halofuginone (Halocur®, MSD Animal Health GmbH, 2 ml/10 kg BW on 7 days,  
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Figure 1. Decision tree for treatment outcome in diarrheic calves infected with Cryptosporidium parvum. Crypto: Cryptos-
poridium parvum; Rota: rotavirus; Corona: coronavirus; Dx: diagnosis; Tx: therapy; AB: antibiotics; P: probability; K: costs; 
RK: risks as probability multiplied by cost.                                                                     
 
 
Figure 2. Decision tree for treatment outcome in diarrheic calves infected with rotavirus. Crypto: Cryptosporidium parvum; 
Rota: rotavirus; Corona: coronavirus; Dx: diagnosis; Tx: therapy; AB: antibiotics; P: probability; K: costs; RK: risks as 
probability multiplied by cost.                                                                              
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Figure 3. Decision tree for treatment outcome in diarrheic calves infected with coronavirus. Crypto: Cryptosporidium par-
vum; Rota: rotavirus; Corona: coronavirus; Dx: diagnosis; Tx: therapy; AB: antibiotics; P: probability; K: costs; RK: risks as 
probability multiplied by cost.                                                                              
 
 
Figure 4. Decision tree for treatment outcome in diarrheic calves infected with E. coli. Crypto: Cryptosporidium parvum; 
Rota: rotavirus; Corona: coronavirus; Dx: diagnosis; Tx: therapy; AB: antibiotics; ABN: N = choice, i.e. first, second or third 
choice according to materials and methods; AB special: Choice of AB according to bacteriological examination and resis-
tance test. P: probability; K: costs; RK: risks as probability multiplied by cost.                                        
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Figure 5. Decision tree for outcome of diarrhea in calves. Crypto: cryptosporidiosis; Rota: rotavirus; Corona: coronavirus. P: 
probability; RK: risks as probability multiplied by the cost.                                                     
 
100 µg/kg BW on 7 days), rotavirus and coronaviruses: symptomatic therapy with rehydration, E. coli: antibio-
tics). The order of antibiotics was chosen according to the treatment guidelines used at our clinic [4]: 1st choice: 
Ampicillin (Albipen® LA, MSD Animal Health GmbH, Switzerland, Ampicillinum anhydricum 100 mg, E312 
0.0875 mg; Aluminii monostearas, Oleum cocos ad susp. pro 1 ml), 2nd choice: trimethoprim-sulfonamide 
(Borgal® 24%, MSD Animal Health GmbH, Sulfadoxinum 200 mg, Trimethoprimum 40 mg, Natrii hydroxidum, 
Glyceroli formalum, Aqua ad iniectabilia pro 1 ml), 3rd choice: enrofloxacin (Baytril® 10%, Provet AG, Swit-
zerland, Enrofloxacinum 100 mg, Kalii hydroxidum, Alcohol butylicus, Aqua ad iniectabilia qs ad 1 ml). 
Treatment success was defined as resolution of diarrhea in a sick calf or survival of a treated calf. Treatment 
failure was defined as continuation of diarrhea despite treatment, death of the calf, or the need to euthanize the 
calf on humane grounds. Information regarding the spontaneous cure rate in calves with diarrhea was gained 
from studies that used placebo-treated control groups of experimentally or naturally infected calves (references 
are given in Tables 3-5). Spontaneous cure was defined as resolution of diarrhea in the absence of treatment or 
survival of a diarrheic calf with resolution of diarrhea. Prevalence of different infectious agents is given in Ta-
ble 1. Treatment success and spontaneous cure rates are shown in Table 2 for diarrheic calves with cryptospori-
diosis, in Table 3 for calves infected with rotavirus, in Table 4 for calves infected with coronavirus, and in Ta-
ble 5 for calves with E. coli diarrhea. The dosages and prices used for calculation in Tables 6-8 are based on the 
fee schedule of our clinic as of June 2015. For calculations, the amount of 0.00 CHF (Swiss Francs) was used 
for a surviving calf, 500.00 CHF was used for a dead calf, and 5.00 CHF was used for the cost of treatment, di-
agnostic testing, and to account for the loss in weight gain per day [23]. 
3. Results 
The prevalence of important pathogens causing diarrhea in neonatal calves in Switzerland is shown in Table 1 
and the prevalence of treatment success for different pathogens is shown in Tables 2-5. Prevalence is used to 
express probabilities. The cost of treatment is given in Tables 6-8 and the steps in the decision tree explain how 
the cost was calculated. Individual risks are additive and generate the total risk contained in a main branch of the 
decision tree [23]. Table 9 shows the formulae for the risk calculations (RK) for the fields C1 to C4 in Figures 
1-5. For clarity, the branches for cryptosporidiosis (Figure 1), rotavirus (Figure 2), coronavirus (Figure 3) and 
E. coli (Figure 4) are shown separately. Figure 5 provides a synopsis of Figures 1-4 and details the costs asso-
ciated with the different branches. An infectious pathogen was isolated in 85% of scouring calves in a Swiss 
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Table 1. Prevalence of major pathogens causing diarrhea in calves in Switzerland.                                    
Definition Etiology Prevalence Source N 
Prevalence General infectious influenza etiology 
91.2% [5] 147 
>78.0% [3] 46 
Herd prevalence  
of major pathogens 
Cryptosporidium parvum 41.7% 
[5] 147 
Rotavirus 52.1% 
Coronaviruses 2.1% 
E. coli K99 2.1% 
Prevalence of major  
pathogens in diarrheic calves 
Cryptosporidium parvum 43.0% 
[3] 46 
Rotavirus 46.0% 
Coronaviruses 0.0% 
E. coli K99 0.0% 
 
Table 2. Therapeutic success and spontaneous cure rate in diarrheic calves infected with Cryptosporidium parvum.          
 Prevalence Definition Source n 
Tx success 
65.0% Treatment with halofuginone, no diarrhea on day 7 (dosage: 100 µg/kg/day) [10] 30 
46.0% Treatment with halofuginone, no diarrhea and  no shedding of oocysts on day 7 (dosage: 100 µg/kg/day) [11] 50 
100.0% Treatment with halofuginone, no diarrhea (60 µg/kg/day and 120 µg/kg/day) [12] 10 
Spontaneous cure rate 
75.0% Placebo-treated calves, no diarrhea on day 20 [13] 24 
65.0% Untreated calves, no diarrhea on day 10 [10] 30 
55.0% Placebo-treated calves, no diarrhea on day 14 [11] 47 
Tx: treatment. 
 
Table 3. Therapeutic success and spontaneous cure rate in diarrheic calves infected with rotavirus.                                
 Prevalence Definition Source N 
Tx success 
100.0% Clinically healthy after treatment with OES [14] 11 
79.0% Clinically healthy after intravenous rehydration [15] 19 
83.0% 
92.0% 
Survival rate after treatment with OES/bicarbonate 
Survival rate after treatment with OES/acetate [16] 12 
Spontaneous cure rate 
75.0% Survival rate 30 days after experimental infection with rotavirus [17] 12 
<33.0% Survival rate after treatment with OES without alkalizing component [16] 12 
Tx: treatment; OES: oral electrolyte solution. 
 
Table 4. Therapeutic success and spontaneous cure rate in diarrheic calves infected with coronaviruses.                    
 Prevalence Definition Source N 
Tx success 
80.0% Clinically healthy after treatment with OES [14] 15 
79.0% Clinically healthy after intravenous rehydration [15] 19 
83.0% 
92.0% 
Survival rate after treatment with OES/bicarbonate 
Survival rate after treatment with OES/acetate [16] 12 
Spontaneous cure rate <33.0% Survival rate after treatment with OES without alkalizing component [16] 12 
Tx: treatment; OES: oral electrolyte solution. 
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Table 5. Therapeutic success and spontaneous cure rate in diarrheic calves infected with E. coli. The therapeutic success is 
based on results of susceptibility testing of isolated fecal E. coli strains to various antibiotics.                                
 Prevalence Definition Source N 
Tx success 
25.0% 
73.3% 
96.5% 
Resistance against. 
Ampicillin (1st choice) 
Trimethoprim-Sulphonamide 
(2nd choice) 
Enrofloxacin (3rd choice) 
[18] NA 
72.7% Resistance against. Ampicillin (1st choice) [19] 176 
72.6% 
86.3% 
Resistance against. 
Ampicillin (1st choice) 
Enrofloxacin (3rd choice) 
[20] 95 
 
40.6% 
68.8% 
100.0% 
Resistance against. 
Ampicillin (1st choice) 
Trimethoprim-Sulphonamide 
(2nd choice) 
Enrofloxacin (3rd choice) 
[21] 251 
Spontaneous cure rate 
22.2% Mortality in calves infected with E. coli B44 [6] 9 
0.0% Mortality in calves infected with E. coli B44 [22] 4 
18.0% Mortality in calves infected with E. coli B44 [8] 11 
Tx: Treatment; NA: not available. 
 
Table 6. Treatment costs for diarrheic calves infected Cryptosporidia based on the fee schedule at our clinic as of June 2015 
and [23].                                                                                               
Decision§ Diagnostics Treatment Costs (CHF) 50 kg BW calf 
D1 
Dx cryptosporidiosis. 
Veterinary visit and  
laboratory fecal examination 
(without susceptibility testing) 
Visit 
professional fee 15 min, clinical examination 
fecal sampling 
PU, VU, BU 
30.00 
28.50 
18.60 
4.60 
90.00 
Total 171.10 
D2 
No Dx. 
Veterinary visit,  
no laboratory  
examination 
Visit 
professional fee 15 min, clinical examination 
30.00 
28.50 
18.60 
Total 77.10 
E1 Tx cryptosporidiosis 
Halofuginone 
Vitamin injection 
24.50 
11.00 
Total 35.50 
E2 Tx antibiotics 
Trimethoprim sulfadoxine 
Injection i/v or i/m 
Vitamin injection 
3.75 
6. 00 
11.00 
Total 20.75 
F1, F3 Calf survived 
Daily loss over 10 days 50.00 
Total 50.00 
F2, F4 Loss of calf 
Daily loss over 10 days 
Loss of calf 
50.00 
500.00 
Total 550.00 
Dx: diagnosis; Tx: treatment; PU: parasitological examination; VU: viral examination; BU: bacteriological examination; CHF: Swiss francs; BW: 
body weight; i/v: intravenous; i/m: intramuscular; s/c: subcutaneous. §: decision according to decision tree in Figures 1-4. 
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Table 7. Treatment costs for diarrheic calves infected with rotavirus and coronavirus based on the fee schedule at our clinic 
as of June 2015 and [23].                                                                                  
Decision§ Diagnostics Treatment Costs (CHF) 50 kg BW calf 
D3, D5 
Dx rotavirus, Dx coronavirus.  
Veterinary visit and laboratory  
fecal examination  
(without susceptibility testing) 
Visit 
professional fee 15min 
clinical examination 
fecal sampling 
PU, VU, BU 
30.00 
28.50 
18.60 
4.60 
90.00 
Total 171.10 
D4, D6 
No Dx. 
Veterinary visit,  
no laboratory examination 
Visit 
professional fee 15min 
clinical examination 
30.00 
28.50 
18.60 
Total 77.10 
E3, E5 Tx rotavirus, Tx coronavirus 
Placing catheter 
i/v rehydration 
Rehydration p/o for 2 days 
Vitamin injection 
20.70 
15.10 
4.25 
11.00 
Total 51.05 
E4, E6 Tx antibiotics 
Trimethoprim sulfadoxine 
Injection i/v or i/m 
Vitamin injection 
3.75 
6.00 
11.00 
Total 20.75 
F5, F7 
F9, F11 Calf survived 
Daily loss over 10 days 50.00 
Total 50.00 
F6, F8 
F10, F12 Loss of calf 
Daily loss over 10 days 
Loss of calf 
50.00 
500.00 
Total 550.00 
 
Table 8. Treatment costs for diarrheic calves infected with E. coli based on the fee schedule at our clinic as of June 2015 and 
[23].                                                                                                  
Decision§ Diagnostics Treatment Costs (CHF) 50 kg BW calf 
D7 
Dx E. coli. 
Veterinary visit and  
laboratory fecal examination 
(without susceptibility testing) 
Visit 
professional fee 15 min 
clinical examination 
fecal sampling 
PU, VU, BU 
30.00 
28.50 
18.60 
4.60 
90.00 
Total 171.10 
D7.1 Susceptibility testing 
Susceptibility testing 50.00 
Total 50.00 
D7.2 No susceptibility testing 
Susceptibility testing 0.00 
Total 0.00 
D8 
No Dx. 
Veterinary visit,  
no laboratory examination 
Visit 
professional fee 15 min 
clinical 
30.00 
28.50 
18.60 
Total 77.10 
E7 effective AB 
Enrofloxacin 
injection i/v or i/m 
Vitamin injection 
3.45 
6.00 
11.00 
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Continued 
  Total 20.45 
E8.1, E9.1 AB1 
Ampicillin 
Vitamin injection 
5.10 
11.00 
Total 16.10 
E8.2, E9.2 AB2 
Trimethoprim sulfadoxine 
Injection i/v or i/m 
3.75 
6.00 
Total 9.75 
E8.3, E9.3 AB3 
Enrofloxacin 
injection i/v or i/m 
3.45 
6.00 
Total 9.45 
F13, F15, F16,  
F17, F19, F20, F21 Calf survived 
Daily loss over 10 days 50.00 
Total 50.00 
F14, F18, F22 Loss of calf 
Daily loss over 10 days 
loss of calf 
50.00 
500.00 
Total 550.00 
AB: antibiotic; Dx: diagnosis; Tx: treatment; PU: parasitological examination; VU: viral examination; BU: bacteriological examination; CHF: Swiss 
francs; BW: body weight; i/v: intravenous; i/m: intramuscular; s/c: subcutaneous; §: decision according to decision tree in Figures 1-4. 
 
Table 9. Calculation of the risk (RK) for each of the 4 main infectious agents according to Figures 1-4. For probabilities (P) 
see Figures 1-4, for costs CN to FNN see Tables 6-8.                                                               
Decision Calculation 
C1 RK = (P * F1) + (P * F2) + E1 + D1 + (P * F3) + (P * F4) + E2 + D2 
C2 RK = (P * F5) + (P * F6) + E3 + D3 + (P * F7) + (P * F8) + E4 + D4 
C3 RK = (P * F9) + (P * F10) + E5 + D5 + (P * F11) + (P * F12) + E6 + D6 
C4 RK = 
(P * F13) + (P * F14) + E7 + D7.1 + (P * F17) + (P * F18) + E8.3  
+ (P * F16) + E8.2 + (P * F15) + E8.1 + D7.2 + D7 + (P * F21) +. 
(P * F22) + E9.3 + (P * F20) + E9.2 + (P * F19) + E9.1 + D8 
 
study [3], [5]; rotavirus and Cryptosporidium parvum each accounted for 40% to 50% of all cases and corona-
virus and E. coli each accounted for approximately 1% of cases. As can be seen in the decision trees (Figures 
1-4), the costs are higher for all four infectious agents when diagnostic testing was done compared with the tri-
al-and-error method. The risk, defined by probability of occurrence multiplied by cost, is equivalent to CHF 
700.00 to 840.00 for all four infectious agents; it is highest for coronavirus (CHF 835.60) and lowest for rotavi-
rus (CHF 705.60, Figure 5). The branches B2 (non-infectious causes) and C5 (other infectious causes) are also 
shown in Figures 1-5 but detailed calculations were not done. 
4. Discussion 
Calf diarrhea is a complex disease caused by a variety of infectious microorganisms and non-infectious factors. 
Infectious agents include viruses, parasites and bacteria [2]. The decision trees shown in this study are limited to 
a few variations of cost and risk analysis in calves with diarrhea. By virtue of the public health axiom ’intention 
to treat’ [24], only those branches of the decision tree are shown that involve treatment. The premise was that 
calves with diarrhea presented for veterinary examination were either treated or euthanized and that non-treat- 
ment was not an option for humane reasons. 
Some pathogens including Cryptosporidium parvum, rotavirus, and coronavirus have intermittent shedding 
patterns [5] and therefore, negative results must be interpreted accordingly regardless of the sensitivity and spe-
cificity of the tests used. Furthermore, diarrhea pathogens also are commonly isolated from clinically healthy 
calves [5]. 
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Two studies of the prevalence of diarrhea pathogens in calves in Switzerland found an infectious cause in 85% 
of affected calves; 93% of the infectious agents belonged to the four main pathogens Cryptosporidium parvum, 
rotavirus, coronavirus, and E. coli [3] [5]. This is consistent with the observation that 75% - 95% of diarrheic 
calves worldwide are affected by these pathogens [2]. Other potential diarrhea pathogens mentioned in the lite-
rature include vero-cytotoxic and necrotoxic E. coli, bovine torovirus, calicivirus, norovirus, Giardia spp., Sal-
monella spp., Clostridium perfringens type B and C, Eimeria spp., and Campylobacter jejuni [2] but these were 
not considered for calculation in this study. 
The prevalences presented in this study confirm that viral and parasitic pathogens are much more commonly 
involved in calf diarrhea than bacterial pathogens suggesting that in the majority of cases the use of antibiotics is 
not justified. A Swedish study reported that 30% of calves with diarrhea in the first three months of life were 
treated with antibiotics [7], and a similar substantial over-treatment of diarrheic calves with antimicrobial drugs 
was reported in another study [25]. The use of antibiotics for the treatment of calves with diarrhea is controver-
sial [1] and several authors have been critical of this practice [7] [25] [26]. Calves treated prophylactically for 
calf diarrhea during the first two weeks of life with neomycin or tetracycline in the milk had lower weight gain, 
lower feed intake, and more days with diarrhea than calves not receiving antibiotics in the milk. However, the 
use of antimicrobials other than in-milk antimicrobials used in calves with diarrhea, fever, anorexia and depres-
sion was beneficial [27]. The use of antibiotics is recommended in diarrheic calves with systemic signs of dis-
ease including anorexia, dehydration, lethargy, fever, or when the diarrheic stool contains blood or sloughed 
mucous membranes. This is to prevent bacteremia following bacterial overgrowth in the intestines and to reduce 
the duration of the disease and the mortality rate [28]. 
There are three main management tools aimed at the reduction of antimicrobial use in young calves [1]. Ma-
ternal vaccination against enterotoxic E. coli, rotavirus and coronavirus in the last trimester increases specific 
colostral immunity against these pathogens. A sufficient amount of high-quality colostrum fed to newborn 
calves within a few hours after birth prevents failure of passive transfer. Finally, attention to good hygiene and 
other appropriate management factors reduces the pathogen load in the environment. 
Regardless of the etiology of the diarrhea, fluid therapy and replacement of electrolyte deficits are a crucial 
part of treatment of diarrheic calves [26]. The inclusion of an alkalinizing agent in the electrolyte mixture seems 
to be beneficial; between 83% and 92% of diarrheic calves infected with rotavirus or coronavirus recovered after 
treatment with electrolyte solutions that contained bicarbonate or acetate compared with 33% of calves that did 
not receive an alkalinizing agent [16]. 
The decision trees show that empirical treatment of diarrheic calves infected with Cryptosporidium parvum, 
rotavirus or coronavirus in the absence of a diagnostic workup is significantly cheaper than specific treatment 
according to a laboratory diagnosis. This means that from a strictly economic point of view, the indiscriminate 
use of antibiotics compares favorably with targeted treatment based on an etiological diagnosis. This difference 
is caused by the high cost of diagnostic testing. Calves infected with rotavirus or coronavirus receiving fluid 
therapy had a significantly higher survival rate than the same calves treated with antibiotics alone, whereas this 
difference was less pronounced for calves with cryptosporidiosis treated with fluids, antibiotics, or halofuginone 
alone. 
With respect to the branch of the decision tree for E. coli, the costs are highest when bacteriological culture 
and antimicrobial susceptibility testing are carried out. The trial-and-error methods provided cheaper treatment 
even in cases in which three different antibiotics were used consecutively. 
In contrast to calves with pneumonia, in which diagnostic laboratory testing is advantageous from an eco-
nomic standpoint [18] [23], the same does not seem to be true for calves with diarrhea. Nevertheless, the pro-
ducer should always be given the option for additional diagnostic testing, particularly when a herd problem ex-
ists or when antimicrobial misuse is suspected. Once an etiological diagnosis has been made, specific prophy-
lactic measures can be instituted to reduce further cases of diarrhea and associated costs. This will pay off in the 
long term and offset the cost of the initial testing; however, this aspect was not taken into account in these cal-
culations. 
The risk analysis calculations generated costs between CHF 700.00 and 840.00 for diarrheic calves infected 
by any of the four pathogens. The costs are highest for calves infected with coronavirus, which accounts for only 
about 1% of diarrheic calves. The high cost associated with coronavirus diarrhea is attributable mainly to to the 
low spontaneous cure rate and loss of the calf [29]. 
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5. Conclusion 
There is a need for standard operating procedures for the management of diarrhea in young calves when the goal 
is to prevent unnecessary use of antibiotics in diarrheic calves. It is expected that the implementation of standard 
operating procedures for evidenced-based treatment of calves with diarrhea will increase therapeutic costs. This 
is also likely to increase the prices in the entire chain of animal food products. However, if the use of antimi-
crobial drugs must be reduced, consumers must tolerate paying higher food prices. 
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ology of Severe Diarrhoea and Suggested Intravenous Fluid Therapy in Calves of Different Ages under Field Condi-
tions. Acta Veterinaria Brno, 66, 87-94. http://dx.doi.org/10.2754/avb199766020087 
[16] Naylor, J.M., Petrie, L., Rodriguez, M.I. and Skilnick, P. (1990) A Comparison of Three Oral Electrolyte Solutions in 
the Treatment of Diarrheic Calves. Canadian Veterinary Journal, 31, 753-760. 
[17] Castrucci, G., Ferrari, M., Frigeri, F., Traldi, V. and Angelillo, V. (1994) A Study on Neonatal Calf Diarrhea Induced 
by Rotavirus. Comparative Immunology, Microbiology & Infectious Diseases, 17, 321-331. 
http://dx.doi.org/10.1016/0147-9571(94)90051-5 
[18] Eugster, S. (2013) Antibiotikaresistenz in Kälbermastbetrieben. Master’s Thesis, Vetsuisse Faculty, University of Zu-
rich, Zürich. 
M. Hässig, S. Kretschmar 
 
 39 
[19] ARCH-Vet (2013) Bericht über den Vertrieb von Antibiotika in der Veterinärmedizin und das Antibiotikaresistenzmo-
nitoring bei Nutztieren in der Schweiz. Eidgenössisches Departement des Innern, Bundesamt für Lebensmittelsicher-
heit und Veterinärwesen. http://www.anresis.ch/index.php/resistenzdaten-veterinaermedizin.html 
[20] De Verdier, K., Nyman, A., Greko, C. and Bengtsson, B. (2012) Antimicrobial Resistance and Virulence Factors in 
Escherichia coli from Swedish Dairy Calves. Acta Veterinaria Scandinavica, 54, 2. 
http://dx.doi.org/10.1186/1751-0147-54-2 
[21] Pereira, R.V.V., Santos, T.M.A., Bicalho, M.L., Caixeta, L.S., Machado, V.S. and Bicalho, R.C. (2011) Antimicrobial 
Resistance and Prevalence of Virulence Factor Genes in Fecal Escherichia coli of Holstein Calves Fed Milk with and 
without Antimicrobials. Journal of Dairy Science, 94, 4556-4565. http://dx.doi.org/10.3168/jds.2011-4337 
[22] Valente, C., Fruganti, G., Tesei, B., Ciorba, A., Cardaras, P., Floris, A. and Bordoni, E. (1988) Vaccination of Pregnant 
Cows with K99 Antigen of Enterotoxigenic Escherichia coli and Protection by Colostrum in Newborn Calves. Com-
parative Immunology, Microbiology & Infectious Diseases, 11, 189-198.  
http://dx.doi.org/10.1016/0147-9571(88)90037-9 
[23] Hässig, M., Eugster, S. and Lewis, F.I. (2015) Evidence-Based Use of Antibiotics in Meat Calves. Open Journal of 
Veterinary Medicine, 5, 68-72. http://dx.doi.org/10.4236/ojvm.2015.53009 
[24] Bonita, R., Beaglehole, R. and Kjellström, T. (2013) Einführung in die Epidemiologie. WHO Press, Colorado. 
[25] Björkman, C., Svensson, C., Christensson, B. and de Verdier, K. (2003) Cryptosporidium parvum and Giardia intesti-
nalis in Calf Diarrhoea in Sweden. Acta Veterinaria Scandinavica, 44, 145-152. 
http://dx.doi.org/10.1186/1751-0147-44-145 
[26] Grove-White, D. (2007) Practical Intravenous Fluid Therapy in the Diarrhoeic Calf. In Practice, 29, 404-408. 
http://dx.doi.org/10.1136/inpract.29.7.404 
[27] Berge, A.C., Moore, D.A., Besser, T.E. and Sischo, W.M. (2009) Targeting Therapy to Minimize Antimicrobial Use in 
Pre-Weaned Calves: Effects on Health, Growth, and Treatment Costs. Journal of Dairy Science, 92, 4707-4714. 
http://dx.doi.org/10.3168/jds.2009-2199 
[28] Constable, P.D. (2009) Treatment of Calf Diarrhea: Antimicrobial and Ancillary Treatments. Veterinary Clinics of 
North America: Food Animal Practice, 25, 101-120. http://dx.doi.org/10.1016/j.cvfa.2008.10.012 
[29] Heiniger, D., van den Borne, B.H.P., Lechner, I., Tschopp, A., Strabel, D., Steiner, A. and Meier, H. (2014) Kosten- 
Nutzen-Analyse einer Intervention zur Verbesserung der Eutergesundheit in Schweizer Milchviehbetrieben. Schweizer 
Archiv für Tierheilkunde, 156, 473-481. http://dx.doi.org/10.1024/0036-7281/a000634 
